Information Journal Paper
APA:
Copy. (2017). Ocrelizumab: First Global Approval. DRUGS, 77(9), 1035-1041. SID. https://sid.ir/paper/727798/en
Vancouver:
Copy. Ocrelizumab: First Global Approval. DRUGS[Internet]. 2017;77(9):1035-1041. Available from: https://sid.ir/paper/727798/en
IEEE:
Copy, “Ocrelizumab: First Global Approval,” DRUGS, vol. 77, no. 9, pp. 1035–1041, 2017, [Online]. Available: https://sid.ir/paper/727798/en